BPTH
Bio-Path Holdings Inc
Halal Rating :
Last Price
$0.79
Last updated:
Market Cap
-
7D Change
-15.43%
1 Year Change
92.68%
Company Overview
Industries
Exchange
Next Earnings Date
Bio-Path Holdings Inc is a biotechnology company focused on developing therapeutic products that utilize DNAbilize®, its proprietary liposomal delivery and antisense technology. The company's lead product candidate is prexigebersen (BP1001), which targets Grb2 protein and is in clinical development for acute myeloid leukemia and chronic myeloid leukemia. The company is also developing BP1002 targeting Bcl-2 protein for lymphoma and solid tumors.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|
Company Impact
Help us evaluate Bio-Path Holdings Inc's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.